Compare Procter & Gamble Co (PG) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Procter & Gamble Co vs Tenet Healthcare Corporation — how do they compare? Procter & Gamble Co trades at $151.2 (market cap $349.77B), while Tenet Healthcare Corporation trades at $263.45 (market cap $20.98B). The key difference: Procter & Gamble Co is far larger — about 16.7× Tenet Healthcare Corporation's market cap, and Procter & Gamble Co pays a 2.89% dividend while Tenet Healthcare Corporation pays none. Which is the better fit depends on your goals — on Pluang, investors hold Procter & Gamble Co for 131 Days and Tenet Healthcare Corporation for 15 Days on average.
| PG | THC | |
|---|---|---|
Market Cap | $349.77B | $20.98B |
Volume | 10,055,825 | 428,008 |
Sector | Consumer Staples | Health |
52-Week High | $167.18 | $280.77 |
52-Week Low | $138.10 | $161.37 |
Typical Hold Time | 131 Days | 15 Days |
Enterprise Value | $375.61B | $32.06B |
Dividend Yield | 2.89% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Procter & Gamble (PG) trades at $151.23, up 2.31% with strong technical momentum above key support levels. The company demonstrates robust fundamentals with $84.28B revenue, 18.44% net margin, and consistent earnings beats. Recent partnership with the WNBA and supply chain enhancements support growth. Technical indicators show bullish moving averages while RSI remains neutral.
PG offers stable dividend income with 69-year growth history and trades near consensus target of $160.13. Premium valuation metrics present near-term risk if growth moderates. Strong cash flow generation and institutional support provide downside protection amid market volatility.
Tenet Healthcare (THC) trades at $265.42, up 2.15% today, with a bullish technical signal from moving averages and strong support near $257. The company shows robust fundamentals, including a 53.31% ROE and consistent earnings beats, with Q3 2026 results due October 29. Revenue growth is supported by higher revenue per case despite softer surgical volumes, as noted by Zacks on September 24, 2026.
The outlook is positive, with an 81.25% analyst buy rating and a $283.36 consensus price target implying ~7% upside. Risks include sustainability of capital returns amid growth investments and potential volume pressures, but solid cash flow and valuation metrics like a 10.07 P/E suggest room for appreciation if execution continues.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Procter & Gamble Co
The Procter & Gamble Company manufactures and markets consumer products in countries throughout the world. The Company provides products in the laundry and cleaning, paper, beauty care, food and beverage, and health care segments. Procter & Gamble products are sold primarily through mass merchandisers, grocery stores, membership club stores, drug stores, and neighborhood stores.
Read more on PG →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
